http://www.neurology.org/cgi/content/abstract/58/1/143
Neurology 2002;58:143-146
M. Keegan, MD FRCP(C);, A. A. Pineda,
MD, R. L. McClelland, PhD, C. H. Darby, MSc, M. Rodriguez, MD and B. G.
Weinshenker, MD FRCP(C)
From the Department of Neurology
(Drs. Keegan, Rodriguez, and Weinshenker), Division of Transfusion Medicine
(Dr. Pineda), and Department of Health Sciences Research (Dr. McClelland
and C. Darby), Mayo Clinic and Foundation, Rochester, MN.
Brief Communications
The authors reviewed 59 consecutive
patients treated with plasma exchange (PE) for acute, severe attacks of
CNS demyelination at Mayo Clinic from January 1984 through June 2000.
Most patients had relapsing-remitting
MS (n = 22, 37.3%), neuromyelitis optica (NMO) (n = 10, 16.9%), and acute
disseminated encephalomyelitis (n = 10, 16.9%).
PE was followed by moderate or marked
functional improvement in 44.1% of treated patients. Male sex (p = 0.021),
preserved reflexes (p = 0.019), and early initiation of treatment (p =
0.009) were associated with moderate or marked improvement.
Successfully treated patients improved
rapidly following PE, and improvement was sustained.
© 2002 American Academy of Neurology